List of Studies ( Metabolite:3-Methylxanthine)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | Absolute Intensity |
ST000923 | AN001513 | Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease | Feces | Human | Inflammatory bowel disease | The Broad Institute | Abundance |
ST001000 | AN001878 | Gut microbiome structure and metabolic activity in inflammatory bowel disease | Feces | Human | The Broad Institute | Abundance | |
ST002470 | AN004029 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling | Blood | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | Abundance |
ST002471 | AN004033 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Feces | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | Abundance |
ST002247 | AN003670 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | Abundances | |
ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
ST001639 | AN002683 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | AU |
ST002250 | AN003676 | Ramadan diurnal intermittent fasting is associated with significant plasma metabolomics changes in overweight and obese subjects: A prospective cohort study | Blood | Human | Obesity | University of Sharjah | AU |
ST002301 | AN003757 | Serum metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients | Blood | Human | COVID-19 | Sharjah Institute for Medical Research | AU |
ST002553 | AN004204 | Exploring the Impact of Oral Arabic Gum Consumption on Sphingolipid Metabolism and human metabolites in Chronic Kidney Disease: A Mass Spectrometry Analysis | Blood | Human | Chronic kidney disease | Sharjah Institute for Medical Research | AU |
ST003039 | AN004986 | A Non-Targeted Metabolomics Comparative Study on Plasma of Pfizer and Sinopharm COVID- 19 Vaccinated individuals, Assessed by (TIMS-QTOF) Mass Spectrometry. | Blood | Human | COVID-19 | Sharjah Institute for Medical Research | AU |
ST000841 | AN001349 | Metabolomics of muscle in insulin sensitive and resistant obese indivduals. | Muscle | Human | Obesity | University of Michigan | Counts |
ST000842 | AN001356 | Muscle and plasma before and after exercise | Blood | Human | Obesity | University of Michigan | Counts |
ST000992 | AN001618 | Metabolomic Markers of Dietary Patterns in the Costa Rica Study | Blood | Human | Metabolic syndrome | University of Michigan | Counts |
ST002903 | AN004762 | Identification and targeting of microbial putrescine acetylation in bloodstream infections | Blood | Human | Septic shock | Broad Institute of MIT and Harvard | integrated peak area |
ST002903 | AN004763 | Identification and targeting of microbial putrescine acetylation in bloodstream infections | Blood | Human | Septic shock | Broad Institute of MIT and Harvard | integrated peak area |
ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham Women's Hospital | intensity |
ST001236 | AN002054 | Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part II | Blood | Human | Cancer | Broad Institute | Log10(Peak Area) |
ST001237 | AN002055 | Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part III | Blood | Human | Cancer | Broad Institute | Log10(Peak Area) |
ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST000150 | AN000237 | Association of Metabolic Profile and Microbiome in Chronic Pressure Ulcer Wounds | Ulcer biopsies | Human | Enterocolitis | Montana State University | mM/gm tissue |
ST003027 | AN004963 | NMR- and MS-based omics reveal characteristic metabolome atlas and optimize biofluid earlydiagnostic biomarkers for esophageal squamous cell carcinoma (part-Ⅳ) | Tissue | Human | Cancer | Radiology Department, Second Affiliated Hospital, Shantou University Medical College, Shantou | m/z |
ST002535 | AN004170 | Relationships between the gut microbiome and cognitive impairment in residents of long-term aged care. | Feces | Human | Cognitive impairment | South Australian Health and Medical Research Institute | ng/ml |
ST002003 | AN003266 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 4) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | normalized peak height |
ST002027 | AN003297 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) | Blood | Human | UC Davis | normalized peak height | |
ST002020 | AN003290 | TIPs Metabolomics (urine) | Urine | Human | Vanderbilt University Medical Center | osmolality normalized scaled imputed | |
ST002498 | AN004656 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | peak area |
ST002536 | AN004172 | Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma | Thyroid | Human | Cancer | Broad Institute of MIT and Harvard | peak area |
ST002915 | AN004785 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Untargeted Reversed-Phase Negative | Kidney | Rat | University of Michigan | peak area | |
ST000689 | AN001064 | Influence of Noxa knockdown on cell metabolism | Cultured cells | Human | University of Michigan | Peak area | |
ST000693 | AN001072 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II) | Mouse | Fatty liver disease | University of Michigan | Peak area | |
ST000695 | AN001075 | Pilot metabolomics study of aromatase inhibitor associated arthralgias | Blood | Human | Arthralgia | University of Michigan | Peak area |
ST000695 | AN001076 | Pilot metabolomics study of aromatase inhibitor associated arthralgias | Blood | Human | Arthralgia | University of Michigan | Peak area |
ST000696 | AN001080 | Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Mouse | Stress | University of Michigan | Peak area | |
ST000708 | AN001100 | Metabolic effects of weight reduction of very low energy diet vs dietary counseling | Human | University of Michigan | Peak area | ||
ST000711 | AN001110 | Microbial ecology of nontuberculous mycobacteria (NTM) in cystic fibrosis (CF) sputum | Sputum | Human | Cystic fibrosis | University of Michigan | Peak area |
ST000713 | AN001114 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm | Cyst fluid | Human | Cancer | University of Michigan | Peak area |
ST000724 | AN001135 | Red squirrels age related changes | Blood | Squirrel | University of Michigan | Peak area | |
ST000725 | AN001136 | Metabolome, body composition, and muscle performance in children | Blood | Human | University of Michigan | Peak area | |
ST000725 | AN001137 | Metabolome, body composition, and muscle performance in children | Blood | Human | University of Michigan | Peak area | |
ST000748 | AN001173 | Placental cells (BeWo) phthalate exposure metabolomics | Cultured cells | Human | University of Michigan | Peak area | |
ST000749 | AN001174 | Rat amniotic fluid metabolomics | Amniotic fluid | Rat | University of Michigan | Peak area | |
ST000750 | AN001177 | Rat amniotic fluid metabolomics (part II) | Amniotic fluid | Rat | University of Michigan | Peak area | |
ST000756 | AN001187 | Metabolomics of cilia and modulation of renal microcirculation | Blood | Rat | University of Michigan | Peak area | |
ST000758 | AN001191 | Effects of caloric restriction in HCR/LCR rats | Rat | University of Michigan | Peak area | ||
ST000775 | AN001222 | Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study | Blood | Human | Depression | University of Michigan | Peak area |
ST000823 | AN001306 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | Cyst fluid | Human | Cancer | University of Michigan | Peak area |
ST000823 | AN001307 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | Cyst fluid | Human | Cancer | University of Michigan | Peak area |
ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | Peak area |
ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | Peak area |
ST002909 | AN004775 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Peak area |
ST002977 | AN004887 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | Peak area | |
ST003178 | AN005219 | Post-Infectious MECFS at the NIH | Cerebrospinal fluid | Human | Chronic fatigue syndrome | National Institutes of Health | Peak area |
ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | Peak Area |
ST000711 | AN001111 | Microbial ecology of nontuberculous mycobacteria (NTM) in cystic fibrosis (CF) sputum | Sputum | Human | Cystic fibrosis | University of Michigan | Peak area normalized |
ST000721 | AN001128 | Metabolomic Profiles of Recovery from Traumatic Brain Injury | Blood | Human | Trauma | University of Michigan | Peak area normalized |
ST000722 | AN001129 | Metabolomics of Diapause in Aedes albopictus | Eggs | Mosquito | University of Michigan | Peak area normalized | |
ST000726 | AN001138 | Polycystic Ovarian Syndrome(PCOS) metabolomics | Blood | Human | Polycystic ovary syndrome | University of Michigan | Peak area normalized |
ST000743 | AN001159 | Metabolomics of bariatric weight loss | Human | Diabetes | University of Michigan | Peak area normalized | |
ST000743 | AN001160 | Metabolomics of bariatric weight loss | Human | Diabetes | University of Michigan | Peak area normalized | |
ST000744 | AN001163 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Human | Diabetes | University of Michigan | Peak area normalized | |
ST000744 | AN001164 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Human | Diabetes | University of Michigan | Peak area normalized | |
ST000759 | AN001195 | Age and exercise effect on metabolomics in rats | Rat | University of Michigan | Peak area normalized | ||
ST001325 | AN002207 | Obesity and Poor Diet as Susceptibility Factors for Secondhand Smoke in Childhood Asthma | Blood | Human | Asthma | University of Michigan | Peak area normalized |
ST000568 | AN000875 | Metabolomic study on a schizophrenia and type 2 diabetes susceptibility gene | Blood | Human | Diabetes | Shanghai Jiao Tong University Affiliated Sixth People’s Hospital | Peak height |
ST001122 | AN001847 | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part II) | Urine | Human | Interstitial cystitis | University of California, Davis | Peak height |
ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000421 | AN000664 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000567 | AN000871 | Large Scale HILIC Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | Peak intensity |
ST001827 | AN002963 | The pregnancy metabolome from a multi-ethnic pregnancy cohort | Blood | Human | Icahn School of Medicine at Mount Sinai | pmoles/l | |
ST000899 | AN001464 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | raw area counts |
ST001749 | AN002850 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin - Madison | Raw area counts |
ST002818 | AN004588 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002819 | AN004592 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002820 | AN004596 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST001849 | AN002994 | Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I) | Blood | Human | COVID-19 | Washington University, St. Louis | Relative Intensity |
ST002088 | AN003408 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST002089 | AN003412 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | scaled imputed | |
ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST000974 | AN001595 | GC6-74 matabolomic of TB (Part 1: Plasma) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | scaled units |
ST000975 | AN001596 | GC6-74 metabolomics of TB vs healthy (Part 2: Serum) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | scaled units |
ST001515 | AN002513 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Blood | Human | Obesity | Translational Research Institute- AdventHealth Orlando | scaled units |
ST002428 | AN003952 | Mass Spectrometry-based Proteomic and Metabolomic profiling of serum samples for discovery and validation of Tuberculosis diagnostic biomarker signature | Blood | Human | Tuberculosis | ITQB NOVA | ua |
ST002246 | AN003666 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | Unitless Abundances | |
ST001519 | AN002527 | Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) | Feces | Human | Broad Institute of MIT and Harvard | unitless peak areas | |
ST001521 | AN002535 | Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) | Blood | Human | Broad Institute of MIT and Harvard | unitless peak areas |